Barclays PLC Buys 83,412 Shares of Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Barclays PLC lifted its stake in Stereotaxis, Inc. (NYSEAMERICAN:STXS) by 449.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 101,953 shares of the company’s stock after purchasing an additional 83,412 shares during the quarter. Barclays PLC’s holdings in Stereotaxis were worth $208,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in STXS. Charles Schwab Investment Management Inc. lifted its position in Stereotaxis by 10.2% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 167,297 shares of the company’s stock valued at $341,000 after acquiring an additional 15,491 shares in the last quarter. State Street Corp lifted its position in Stereotaxis by 5.7% in the 3rd quarter. State Street Corp now owns 680,612 shares of the company’s stock valued at $1,388,000 after acquiring an additional 36,518 shares in the last quarter. Bank of New York Mellon Corp lifted its position in Stereotaxis by 247.5% in the 2nd quarter. Bank of New York Mellon Corp now owns 189,592 shares of the company’s stock valued at $345,000 after acquiring an additional 135,041 shares in the last quarter. SG Americas Securities LLC bought a new position in shares of Stereotaxis during the 3rd quarter valued at $39,000. Finally, Renaissance Technologies LLC lifted its holdings in shares of Stereotaxis by 46.2% during the 2nd quarter. Renaissance Technologies LLC now owns 488,700 shares of the company’s stock valued at $889,000 after buying an additional 154,400 shares during the period. 45.35% of the stock is owned by institutional investors.

Stereotaxis Trading Up 11.4 %

NYSEAMERICAN STXS opened at $2.64 on Tuesday. The firm has a market cap of $223.69 million, a PE ratio of -9.43 and a beta of 1.57. Stereotaxis, Inc. has a 1-year low of $1.66 and a 1-year high of $3.29.

Stereotaxis (NYSEAMERICAN:STXS) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.08) earnings per share for the quarter, missing the consensus estimate of ($0.05) by ($0.03). The firm had revenue of $9.20 million for the quarter, compared to the consensus estimate of $6.80 million. Stereotaxis had a negative net margin of 85.79% and a negative return on equity of 162.54%. As a group, analysts forecast that Stereotaxis, Inc. will post -0.26 EPS for the current fiscal year.

Stereotaxis Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.